![](https://investorshub.advfn.com/uicon/220347.png?cb=1693474201)
Thursday, January 05, 2017 2:51:45 PM
Also, if I am understanding the filings correctly a maximum of only 2M shares will be sold after the private placements, so there will be a limited supply of shares available. If Dr Jaikaria can manage to create a demand for the stock through his Wall Street contacts, whilst limiting the supply of shares, then this should be quite good.
Now I don't expect NewGen's financials to be very good, if they have a decent cash position I'd be happy, but the fins don't necessarily need to be great either for this to still run. Look at ImmunoCellular, that was around $50 a share while Dr Jaikaria was there, dilution eventually killed it but that didn't happen until the last couple of years.
FEATURED Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM